PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry"

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry"

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2022 - Volume 26, Number 2
View All Articles in Issue

Abstract:

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, U.S. Food and Drug Administration, FDA, Code of Federal Regulations, FDA Guidance for Industry, Federal Food, Drug, and Cosmetic Act section 503A, drug product, pharmaceutical equivalence, pharmaceutical alternatives, finished dosage form

Related Categories: LEGAL, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Download in electronic PDF format for $45

Title (Click for Abstract / Details)	Author	Issue	Page	View/Buy

Related Articles from IJPC
PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry"	Allen Loyd V Jr	Mar/Apr 2022	92	Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines	Allen Loyd V Jr	Jul/Aug 2016	351	View Sample
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA	Cabaleiro Joe	Sep/Oct 2021	358-362	Buy
Allowing Compounding Pharmacies to Address Drug Shortages	Broughel James	Mar/Apr 2022	100-109	Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs	Allen Loyd V Jr	Sep/Oct 2017	356	Buy
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A	Blankenship Cynthia E	Sep/Oct 2014	379-380	Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances	Miller David G	Jul/Aug 2015	303-305	Buy
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)		Nov/Dec 2016	457-458	Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs	Allen Loyd V Jr	Nov/Dec 2015	487-488	Buy
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies	Yoch Doug	Mar/Apr 2017	95-102	Buy

Update Your SOPs and Comply with PCAB/ACHC Standards